Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2025-12-24 @ 7:09 PM
NCT ID:
NCT03718403
Eligibility Criteria:
Inclusion Criteria:
* Subjects with known diagnosis of PHP1A and PHP1B
* Age \>5 years
Exclusion Criteria:
* • Significant kidney disease, i.e. any CKD stage
* Hypercalciuria
* Kidney stones
* Severe Heart disease
* Uncontrolled seizure disorder
* Peptic ulcer
* Liver dysfunction
* Bleeding disorder
* Allergy to theophylline preparation
* Muscle disorder
* Infection
* Any neurologic disease
* Chronic drugs interacting with theophylline
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
21 Years
Study:
NCT03718403
Study Brief:
Protocol Section:
NCT03718403